Topic: GlaxoSmithKline plc
WASHINGTON/NEW YORK (Reuters) - U.S. health regulators have ordered drugmakers to conduct clinical trials involving a total of 53,000 patients to test the safety of a controversial class of inhaled asthma drugs that are already on the market.The trials are being required ...
Has your doctor prescribed Ventolin HFA as a rescue inhaler to treat your asthma? This Ventolin coupons page will help you to save money when you purchase this prescription asthma medication and inhalation device as prescribed by your doctor. Ventolin HFA inhaler ...
Not many events have sufficient gravitas to move shares in ?64bn ($103bn) GlaxoSmithKline (GSK) these days, a fact that puts the significance of Thursday's 3.5% gain into perspective. The trigger was news that Sandoz is backing away from developing a generic version ...
NEW YORK (Reuters Health) - An author of a new industry-funded study on the safety of a commonly prescribed type of inhaled asthma drug says the findings should be " However, two researchers who have published studies of their own on the ...
THRX) today announced positive results from three, separate phase 2b studies assessing efficacy and safety of GSK's inhaled corticosteroid (ICS) fluticasone furoate(FF or GW685698) across a range of eight doses (25 - 800 mcg) in over 1,800 patients with mild, moderate and ...
GSK - news - people ) Plc's widely prescribed drug, Advair, is safe enough for treating asthma, but two lesser-used medicines are too risky, a U.S. advisory panel ruled on Thursday. Evidence of asthma-related deaths and serious complications led the panel of ...
The use of paracetamol (acetaminophen), whether in the first year of life or later in childhood, is associated with higher risk of asthma symptoms at ages 6 and 7, according to research published in the Sept. 20 issue of The Lancet.. The ...
GlaxoSmithKline (nyse: GSK - news - people ) said today it had reached an agreement to update its product label for its popular drug Advair with a strict new warning that advises doctors to limit the use of the drug only to ...
GlaxoSmithKline (nyse: GSK - news - people ) said today it had reached an agreement to update its product label for its popular drug Advair with a strict new warning that advises doctors to limit the use of the drug only to ...
GlaxoSmithKline (nyse: GSK - news - people ) said today it had reached an agreement to update its product label for its popular drug Advair with a strict new warning that advises doctors to limit the use of the drug only to ...